Thank you!
Your email has been successfully added to our mailing list.
CLOSE
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Sign up
Log in
Home
Blog
Resources
Why News Quantified Works
The Ultimate Earnings Guide
STOCK MARKET 101
About Us
Contact
Services
Institutions
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
ACIU
News
ACIU –
ac immune sa
(US:NASDAQ)
DELAYED
<
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
——
ACIU
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
10/19
04:10 pm
aciu
AC Immune SA (
NASDAQ: ACIU
) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
Low
REPORT
10/19
06:40 am
aciu
AC Immune SA (
NASDAQ: ACIU
) had its "outperform" rating re-affirmed by analysts at SVB Leerink LLC.
Low
REPORT
9/21
10:01 am
aciu
AC Immune granted U.S. patent covering Alzheimer's Disease candidate [Seeking Alpha]
Low
REPORT
9/20
04:13 pm
aciu
AC Immune SA (
NASDAQ: ACIU
) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
Low
REPORT
9/3
07:52 am
aciu
AC Immune CEO Andrea Pfeifer Receives First SEF.WomenAward for CEO of the Year
Low
REPORT
9/2
07:00 am
aciu
AC Immune to Participate in Upcoming Virtual Investor Conferences in September
Medium
REPORT
8/31
12:18 pm
aciu
Antibody drug cuts moderate Alzheimer's decline, Swiss biotech cautions over results [FOX News]
Medium
REPORT
8/31
10:01 am
aciu
AC Immune surges after reporting mid-stage data for Alzheimer’s candidate [Seeking Alpha]
High
REPORT
8/31
07:30 am
aciu
AC Immune Announces First Positive Cognitive Results for a Tau-Targeting Monoclonal Antibody in Alzheimer’s Disease
High
REPORT
8/17
04:05 am
aciu
DuChemBio Co., Ltd. & Life Molecular Imaging Announce Material Transfer And Clinical Supply Agreement for [18F]PI-2620 Tau PET Tracer
Low
REPORT
8/8
10:59 am
aciu
AC Immune SA (
NASDAQ: ACIU
) had its "buy" rating re-affirmed by analysts at SVB Leerink LLC. They now have a $17.00 price target on the stock.
Low
REPORT
8/4
07:00 am
aciu
AC Immune Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Low
REPORT
7/29
07:30 am
aciu
AC Immune Presents Full Phase 1b Results on Anti-Abeta Vaccine and Discusses its First-in-Class Diagnostic for Parkinson’s Disease at AAIC 2021
Medium
REPORT
7/27
10:01 am
aciu
AC Immune acquires Parkinson’s disease vaccine candidate, launches private placement [Seeking Alpha]
Low
REPORT
7/27
08:00 am
aciu
AC Immune acquires AFFiRiS’ Specific Active Immunotherapy (SAIT) anti-alpha-synuclein programs targeting neurodegenerative diseases
Low
REPORT
7/27
07:35 am
aciu
AC Immune lures BioNTech investors, buys Parkinson's vaccine candidate [Reuters]
High
REPORT
7/27
07:30 am
aciu
AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH
Medium
REPORT
7/21
04:44 pm
aciu
AC Immune SA (
NASDAQ: ACIU
) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
Low
REPORT
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day